Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease. Spencer EA, Bergstein S, Dolinger M, Pittman N, et al. Inflamm Bowel Dis 2023 Dec 22:izad300. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Spencer EA, Bergstein S, Dolinger M, Pittman N, et al. Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease. Inflamm Bowel Dis 2023 Dec 22:izad300. doi: 10.1093.
PMID: 38134405